Articles

Heron Articles

February 25, 2020PR NewswirePress Release

Heron Therapeutics to Present at the 40th Annual Cowen Healthcare Conference

SAN DIEGO, Feb. 25, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage ... See more »
February 18, 2020PR NewswirePress Release

Heron Therapeutics to Present at the 9th Annual SVB Leerink Global Healthcare Conference

SAN DIEGO, Feb. 18, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage ... See more »
January 13, 2020MarketScreenerNews

Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises

(marketscreener.com) SAN DIEGO, Jan. 13, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. , a commercial... See more »
January 5, 2020BioPortfolioNews

Heron Therapeutics Inc HRTX Financial and Strategic SWOT Analysis Review Report Updated 09052019 Prices from USD $106

Heron Therapeutics Inc HRTX Financial and Strategic SWOT Analysis Review provides you an indepth stra... See more »
December 16, 2019centralchartsPress Release

Heron Therapeutics Announces Publication of the Mechanism of Action Data for HTX-011, a Dual-Acting Local Anesthetic Being Developed for Management of Postoperative Pain

Heron Therapeutics Announces Publication of the Mechanism of Action Data for HTX-011, a Dual-Acting L... See more »
December 3, 2019MarketScreenerNews

Health Canada Grants Priority Review Status for Heron Therapeutics' New Drug Submission for HTX-011 for Management of Postoperative Pain

(marketscreener.com) SAN DIEGO, Dec. 3, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX),... See more »
November 15, 2019Seeking AlphaNews

Looking Solid Heading Into 2020

October 28, 2019MarketScreenerNews

Heron Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for HTX-011 for Management of Postoperative Pain

(marketscreener.com) SAN DIEGO, Oct. 28, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX)... See more »
October 4, 2019Seeking AlphaNews

Priming The Fuse

October 4, 2019firstwordpharmaNews

Heron Therapeutics Announces Pricing of Public Offering of Common Stock

SAN DIEGO, Oct. 3, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. ("Heron") (NASDAQ: HRTX), a commerci... See more »
July 30, 2019GlobalNewswirePress Release

Bernstein Liebhard LLP Reminds Investors That Approximately 6 Days Remain To Make A Motion For Lead Plaintiff In A Securities Class Action Lawsuit Against Heron Therapeutics, INC. - HRTX

NEW YORK, July 30, 2019 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor r... See more »
July 1, 2019NewswisePress Release

American Society of Anesthesiologists Announces New Industry Supporter Heron Therapeutics

ASA today announced Heron Therapeutics, Inc., a developer of novel, pharmaceutical treatments to redu... See more »
June 19, 2019GlobalNewswirePress Release

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, Heron Therapeutics, Mammoth Energy, and ChinaCache and Encourages Investors to Contact the Firm

NEW YORK, June 18, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class ... See more »
June 14, 2019GlobalNewswirePress Release

Pawar Law Group Announces a Securities Class Action Lawsuit Against Heron Therapeutics, Inc. - HRTX

NEW YORK, June 14, 2019 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has... See more »
May 29, 2019PR NewswirePress Release

Heron Therapeutics to Present at Jefferies 2019 Healthcare Conference

SAN DIEGO, May 29, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage b... See more »
May 21, 2019PR NewswirePress Release

Heron Therapeutics Announces Publication of Results from Phase 3 EPOCH 1 Study of HTX-011 in Patients Undergoing Bunionectomy

SAN DIEGO, May 21, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage b... See more »
May 8, 2019PR NewswirePress Release

Heron Therapeutics to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference

SAN DIEGO, May 8, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage bi... See more »
Loading interface...
Loading interface...
Loading interface...
Loading interface...